{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:16:31Z","timestamp":1793304991132,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Col\u00b7legi Oficial de Farmac\u00e8utics de Barcelona"},{"name":"Maria Zambrano fellowship, Spanish Ministry of Science, Innovation and Universities"},{"name":"Beatriu de Pin\u00f3s fellowship, Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca"},{"name":"Miguel Servet Fellowship from the Spanish Health Institute Carlos III","award":["CP22\/00078"],"award-info":[{"award-number":["CP22\/00078"]}]},{"name":"Miguel Servet Fellowship from the Spanish Health Institute Carlos III","award":["CP21\/00032"],"award-info":[{"award-number":["CP21\/00032"]}]},{"name":"Spanish State Research Agency corresponding to \u201cProyectos de Generaci\u00f3n del Conocimiento 2022\u201d","award":["PID2022- 143269OB-I00"],"award-info":[{"award-number":["PID2022- 143269OB-I00"]}]},{"name":"Spanish State Research Agency corresponding to \u201cProyectos de Generaci\u00f3n del Conocimiento 2021\u201d","award":["PID2021-124465OA-I00"],"award-info":[{"award-number":["PID2021-124465OA-I00"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-024-03323-0","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T15:59:08Z","timestamp":1734969548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Regulatory T cell expansion prevents retinal degeneration in type 2 diabetes"],"prefix":"10.1186","volume":"21","author":[{"given":"Mar\u00eda","family":"Llori\u00e1n-Salvador","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"P\u00e9rez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Duarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Garc\u00eda-Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"De\u00e0s-Just","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"\u00c1lvarez-Guaita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Ramos-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Bogdanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Gomez-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan W.","family":"Stitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alerie G.","family":"de la Fuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Sim\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"3323_CR1","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. https:\/\/doi.org\/10.1016\/j.diabres.2021.109119.","journal-title":"Diabetes Res Clin Pract"},{"key":"3323_CR2","doi-asserted-by":"publisher","first-page":"16012","DOI":"10.1038\/nrdp.2016.12","volume":"2","author":"TY Wong","year":"2016","unstructured":"Wong TY, Cheung CMG, Larsen M, Sharma S, Sim\u00f3 R. Diabetic retinopathy. Nat Rev Dis Primers. 2016;2:16012. https:\/\/doi.org\/10.1038\/nrdp.2016.12.","journal-title":"Nat Rev Dis Primers"},{"key":"3323_CR3","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","volume":"9","author":"RRA Bourne","year":"2021","unstructured":"Bourne RRA, Steinmetz JD, Saylan M, Mersha AM, Weldemariam AH, Wondmeneh TG, et al. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: The Right to Sight: An analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9:e144\u201360. https:\/\/doi.org\/10.1016\/S2214-109X(20)30489-7.","journal-title":"Lancet Glob Health"},{"key":"3323_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2337\/dc16-2641","volume":"40","author":"SD Solomon","year":"2017","unstructured":"Solomon SD, Chew E, Duh EJ, Sobrin L, Sun JK, VanderBeek BL, et al. Diabetic retinopathy: A position statement by the American Diabetes Association. Diabetes Care. 2017;40:412\u20138. https:\/\/doi.org\/10.2337\/dc16-2641.","journal-title":"Diabetes Care"},{"key":"3323_CR5","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1007\/s00125-018-4692-1","volume":"61","author":"R Sim\u00f3","year":"2018","unstructured":"Sim\u00f3 R, Stitt AW, Gardner TW. Neurodegeneration in diabetic retinopathy: does it really matter? Diabetologia. 2018;61:1902\u201312. https:\/\/doi.org\/10.1007\/s00125-018-4692-1.","journal-title":"Diabetologia"},{"key":"3323_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.diabet.2011.11.006","volume":"38","author":"MC Calle","year":"2012","unstructured":"Calle MC, Fernandez ML. Inflammation and type 2 diabetes. Diabetes Metab. 2012;38:183\u201391. https:\/\/doi.org\/10.1016\/j.diabet.2011.11.006.","journal-title":"Diabetes Metab"},{"key":"3323_CR7","doi-asserted-by":"publisher","first-page":"583687","DOI":"10.3389\/fimmu.2020.583687","volume":"11","author":"JV Forrester","year":"2020","unstructured":"Forrester JV, Kuffova L, Delibegovic M. The Role of Inflammation in Diabetic Retinopathy. Front Immunol. 2020;11:583687. https:\/\/doi.org\/10.3389\/fimmu.2020.583687.","journal-title":"Front Immunol"},{"key":"3323_CR8","doi-asserted-by":"publisher","unstructured":"Xue M, Mao X, Chen M, Yin W, Yuan S, Liu Q. The Role of Adaptive Immunity in Diabetic Retinopathy. J Clin Med. 2022;11. https:\/\/doi.org\/10.3390\/jcm11216499.","DOI":"10.3390\/jcm11216499"},{"key":"3323_CR9","doi-asserted-by":"publisher","unstructured":"Yue T, Shi Y, Luo S, Weng J, Wu Y, Zheng X. The role of inflammation in immune system of diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications. Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.1055087.","DOI":"10.3389\/fimmu.2022.1055087"},{"key":"3323_CR10","doi-asserted-by":"crossref","unstructured":"Cant\u00f3n A, Martinez EM. CD4-CD8 and CD28 expression in T Cells infiltrating the vitreous fluid in patients with proliferative diabetic retinopathy a flow cytometric analysis. 2004;122.","DOI":"10.1001\/archopht.122.5.743"},{"key":"3323_CR11","doi-asserted-by":"publisher","unstructured":"Llori\u00e1n-Salvador M, Cabeza-Fern\u00e1ndez S, Gomez-Sanchez JA, de la Fuente AG. Glial cell alterations in diabetes-induced neurodegeneration. Cell Mol Life Sci. 2024;81. https:\/\/doi.org\/10.1007\/s00018-023-05024-y.","DOI":"10.1007\/s00018-023-05024-y"},{"key":"3323_CR12","doi-asserted-by":"publisher","unstructured":"Byrne EM, Llori\u00e1n-Salvador M, Tang M, Margariti A, Chen M, Xu H. Il-17a damages the blood\u2013retinal barrier through activating the janus kinase 1 pathway. Biomedicines 2021;9. https:\/\/doi.org\/10.3390\/biomedicines9070831","DOI":"10.3390\/biomedicines9070831"},{"key":"3323_CR13","doi-asserted-by":"publisher","unstructured":"Evans FL, Dittmer M, de la Fuente AG, Fitzgerald DC. Protective and Regenerative Roles of T Cells in Central Nervous System Disorders. Front Immunol. 2019;10. https:\/\/doi.org\/10.3389\/fimmu.2019.02171.","DOI":"10.3389\/fimmu.2019.02171"},{"key":"3323_CR14","doi-asserted-by":"publisher","unstructured":"Okeke EB, Uzonna JE. The pivotal role of regulatory T cells in the regulation of innate immune cells. Front Immunol. 2019;10. https:\/\/doi.org\/10.3389\/fimmu.2019.00680.","DOI":"10.3389\/fimmu.2019.00680"},{"key":"3323_CR15","doi-asserted-by":"publisher","unstructured":"MacHhi J, Kevadiya BD, Muhammad IK, Herskovitz J, Olson KE, Mosley RL, et al. Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders. Mol Neurodegener. 2020;15. https:\/\/doi.org\/10.1186\/s13024-020-00375-7.","DOI":"10.1186\/s13024-020-00375-7"},{"key":"3323_CR16","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nn.4528","volume":"20","author":"Y Dombrowski","year":"2017","unstructured":"Dombrowski Y, O\u2019Hagan T, DIttmer M, Penalva R, Mayoral SR, Bankhead P, et al. Regulatory T cells promote myelin regeneration in the central nervous system. Nat Neurosci. 2017;20:674\u201380. https:\/\/doi.org\/10.1038\/nn.4528.","journal-title":"Nat Neurosci"},{"key":"3323_CR17","doi-asserted-by":"publisher","unstructured":"Lemaitre P, Tareen SH, Pasciuto E, Mascali L, Martirosyan A, Callaerts-Vegh Z, et al. Molecular and cognitive signatures of ageing partially restored through synthetic delivery of IL2 to the brain. EMBO Mol Med. 2023;15. https:\/\/doi.org\/10.15252\/emmm.202216805.","DOI":"10.15252\/emmm.202216805"},{"key":"3323_CR18","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41590-022-01208-z","volume":"23","author":"L Yshii","year":"2022","unstructured":"Yshii L, Pasciuto E, Bielefeld P, Mascali L, Lemaitre P, Marino M, et al. Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulatory T cell numbers and protects against pathological neuroinflammation. Nat Immunol. 2022;23:878\u201391. https:\/\/doi.org\/10.1038\/s41590-022-01208-z.","journal-title":"Nat Immunol"},{"key":"3323_CR19","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1007\/s00415-023-11690-6","volume":"270","author":"C Louapre","year":"2023","unstructured":"Louapre C, Rosenzwajg M, Golse M, Roux A, Pitoiset F, Adda L, et al. A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing\u2013remitting multiple sclerosis. J Neurol. 2023;270:4403\u201314. https:\/\/doi.org\/10.1007\/s00415-023-11690-6.","journal-title":"J Neurol"},{"key":"3323_CR20","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1084\/jem.20082824","volume":"206","author":"KE Webster","year":"2009","unstructured":"Webster KE, Walters S, Kohler RE, Mrkvan T, Boyman O, Surh CD, et al. In vivo expansion of t reg cells with il-2-mab complexes: induction of resistance to eae and long-term acceptance of islet allografts without immunosuppression. J Exp Med. 2009;206:751\u201360. https:\/\/doi.org\/10.1084\/jem.20082824.","journal-title":"J Exp Med"},{"key":"3323_CR21","doi-asserted-by":"publisher","unstructured":"Llori\u00e1n-Salvador M, de Fuente AG, McMurran CE, Dashwood A, Dooley J, Liston A et al. Regulatory T cells limit age-associated retinal inflammation and neurodegeneration. Mol Neurodegener 2024;19. https:\/\/doi.org\/10.1186\/s13024-024-00724-w","DOI":"10.1186\/s13024-024-00724-w"},{"key":"3323_CR22","doi-asserted-by":"publisher","unstructured":"Qiao YC, Shen J, He L, Hong XZ, Tian F, Pan YH et al. Changes of Regulatory T Cells and of Proinflammatory and Immunosuppressive Cytokines in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. J Diabetes Res. 2016;2016. https:\/\/doi.org\/10.1155\/2016\/3694957","DOI":"10.1155\/2016\/3694957"},{"key":"3323_CR23","doi-asserted-by":"publisher","unstructured":"Sheikh V, Zamani A, Mahabadi-Ashtiyani E, Tarokhian H, Borzouei S, Alahgholi\u2010Hajibehzad M. Decreased regulatory function of CD4\u2009+\u2009CD25\u2009+\u2009CD45RA\u2009+\u2009T cells and impaired IL\u20102 signalling pathway in patients with type 2 diabetes mellitus. Scand J Immunol. 2018;88. https:\/\/doi.org\/10.1111\/sji.12711.","DOI":"10.1111\/sji.12711"},{"key":"3323_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.clim.2018.09.005","volume":"197","author":"M Wang","year":"2018","unstructured":"Wang M, Chen F, Wang J, Zeng Z, Yang Q, Shao S. Th17 and Treg lymphocytes in obesity and Type 2 diabetic patients. Clin Immunol. 2018;197:77\u201385. https:\/\/doi.org\/10.1016\/j.clim.2018.09.005.","journal-title":"Clin Immunol"},{"key":"3323_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-00751-w","volume":"8","author":"D Deliyanti","year":"2017","unstructured":"Deliyanti D, Talia DM, Zhu T, Maxwell MJ, Agrotis A, Jerome JR, et al. Foxp3\u2009+\u2009Tregs are recruited to the retina to repair pathological angiogenesis. Nat Commun. 2017;8:1\u201312. https:\/\/doi.org\/10.1038\/s41467-017-00751-w.","journal-title":"Nat Commun"},{"key":"3323_CR26","doi-asserted-by":"publisher","first-page":"e97302","DOI":"10.1371\/journal.pone.0097302","volume":"9","author":"P Bogdanov","year":"2014","unstructured":"Bogdanov P, Corraliza L, Villena A, Carvalho J, Garcia-Arum\u00ed AR, Ramos J. The db\/db Mouse: A Useful Model for the Study of Diabetic Retinal Neurodegeneration. PLoS ONE. 2014;9:e97302.","journal-title":"PLoS ONE"},{"key":"3323_CR27","doi-asserted-by":"publisher","unstructured":"Ren J, Zhang S, Pan Y, Jin M, Li J, Luo Y, et al. Diabetic retinopathy: Involved cells, biomarkers, and treatments. Front Pharmacol. 2022;13. https:\/\/doi.org\/10.3389\/fphar.2022.953691.","DOI":"10.3389\/fphar.2022.953691"},{"key":"3323_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.preteyeres.2014.07.001","volume":"43","author":"N Cuenca","year":"2014","unstructured":"Cuenca N, Fern\u00e1ndez-S\u00e1nchez L, Campello L, Maneu V, De la Villa P, Lax P, et al. Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases. Prog Retin Eye Res. 2014;43:17\u201375. https:\/\/doi.org\/10.1016\/j.preteyeres.2014.07.001.","journal-title":"Prog Retin Eye Res"},{"key":"3323_CR29","doi-asserted-by":"publisher","unstructured":"Liu F, Saul AB, Pichavaram P, Xu Z, Rudraraju M, Somanath PR, et al. Pharmacological inhibition of spermine oxidase reduces neurodegeneration and improves retinal function in diabetic mice. J Clin Med. 2020;9. https:\/\/doi.org\/10.3390\/jcm9020340.","DOI":"10.3390\/jcm9020340"},{"key":"3323_CR30","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1167\/iovs.05-1376","volume":"47","author":"MJ Gastinger","year":"2006","unstructured":"Gastinger MJ, Singh RSJ, Barber AJ. Loss of Cholinergic and Dopaminergic Amacrine Cells in Streptozotocin-Diabetic Rat and Ins2 Akita -Diabetic Mouse Retinas. Invest Opthalmology Visual Sci. 2006;47:3143. https:\/\/doi.org\/10.1167\/iovs.05-1376.","journal-title":"Invest Opthalmology Visual Sci"},{"key":"3323_CR31","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1038\/s41433-018-0110-7","volume":"32","author":"M Ma","year":"2018","unstructured":"Ma M, Xu Y, Xiong S, Zhang J, Gu Q, Ke B, et al. Involvement of ciliary neurotrophic factor in early diabetic retinal neuropathy in streptozotocin-induced diabetic rats. Eye. 2018;32:1463\u201371. https:\/\/doi.org\/10.1038\/s41433-018-0110-7.","journal-title":"Eye"},{"key":"3323_CR32","doi-asserted-by":"publisher","unstructured":"Altmann C, Schmidt MHH. The role of microglia in diabetic retinopathy: Inflammation, microvasculature defects and neurodegeneration. Int J Mol Sci. 2018;19. https:\/\/doi.org\/10.3390\/ijms19010110.","DOI":"10.3390\/ijms19010110"},{"key":"3323_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.visres.2017.03.013","volume":"139","author":"BA Coughlin","year":"2017","unstructured":"Coughlin BA, Feenstra DJMS. M\u00fcller Cells and Diabetic Retinopathy. Vis Res. 2017;139:93\u2013100. https:\/\/doi.org\/10.1016\/j.visres.2017.03.013.","journal-title":"Vis Res"},{"key":"3323_CR34","doi-asserted-by":"publisher","unstructured":"Voet S, Srinivasan S, Lamkanfi M, van Loo G. Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol Med. 2019;11. https:\/\/doi.org\/10.15252\/emmm.201810248.","DOI":"10.15252\/emmm.201810248"},{"key":"3323_CR35","doi-asserted-by":"publisher","unstructured":"Zheng X, Wan J, Tan G. The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in diabetic retinopathy. Front Immunol. 2023;14. https:\/\/doi.org\/10.3389\/fimmu.2023.1151185.","DOI":"10.3389\/fimmu.2023.1151185"},{"key":"3323_CR36","doi-asserted-by":"publisher","unstructured":"McCurry CM, Sunilkumar S, Subrahmanian SM, Yerlikaya EI, Toro AL, VanCleave AM, et al. NLRP3 Inflammasome Priming in the Retina of Diabetic Mice Requires REDD1-Dependent Activation of GSK3\u03b2. Invest Ophthalmol Vis Sci. 2024;65. https:\/\/doi.org\/10.1167\/iovs.65.3.34.","DOI":"10.1167\/iovs.65.3.34"},{"key":"3323_CR37","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1007\/s00125-011-2200-y","volume":"54","author":"MB Sasongko","year":"2011","unstructured":"Sasongko MB, Wong TY, Nguyen TT, Cheung CY, Shaw JE, Wang JJ. Retinal vascular tortuosity in persons with diabetes and diabetic retinopathy. Diabetologia. 2011;54:2409\u201316. https:\/\/doi.org\/10.1007\/s00125-011-2200-y.","journal-title":"Diabetologia"},{"key":"3323_CR38","doi-asserted-by":"publisher","unstructured":"Sim\u00f3 R, Bogdanov P, Ramos H, Huerta J, Sim\u00f3-Servat O, Hern\u00e1ndez C. Effects of the topical administration of semaglutide on retinal neuroinflammation and vascular leakage in experimental diabetes. Biomedicines. 2021;9. https:\/\/doi.org\/10.3390\/biomedicines9080926.","DOI":"10.3390\/biomedicines9080926"},{"key":"3323_CR39","doi-asserted-by":"crossref","unstructured":"Gupta N, Mansoor S, Sharma A, Sapkal A, Sheth J, Falatoonzadeh P et al. Diabetic Retinopathy and VEGF. 2013;7.","DOI":"10.2174\/1874364101307010004"},{"key":"3323_CR40","doi-asserted-by":"publisher","unstructured":"Burke SJ, Batdorf HM, Burk DH, Noland RC, Eder AE, Boulos MS, et al. Db \/ db Mice Exhibit Features of Human Type 2 Diabetes That Are Not Present in Weight-Matched C57BL\/6J Mice Fed a Western Diet. J Diabetes Res. 2017;2017. https:\/\/doi.org\/10.1155\/2017\/8503754.","DOI":"10.1155\/2017\/8503754"},{"key":"3323_CR41","doi-asserted-by":"publisher","unstructured":"Sheikh V, Zamani A, Mahabadi-Ashtiyani E, Tarokhian H, Borzouei S, Alahgholi-Hajibehzad M. Decreased regulatory function of CD4\u2009+\u2009CD25\u2009+\u2009CD45RA\u2009+\u2009T cells and impaired IL-2 signalling pathway in patients with type 2 diabetes mellitus. Scand J Immunol. 2018;88. https:\/\/doi.org\/10.1111\/sji.12711.","DOI":"10.1111\/sji.12711"},{"key":"3323_CR42","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s10020-022-00574-6","volume":"28","author":"Q Xu","year":"2022","unstructured":"Xu Q, Zhang X, Li T, Shao S. Exenatide regulates Th17\/Treg balance via PI3K\/Akt\/FoxO1 pathway in db\/db mice. Mol Med. 2022;28:144. https:\/\/doi.org\/10.1186\/s10020-022-00574-6.","journal-title":"Mol Med"},{"key":"3323_CR43","doi-asserted-by":"publisher","first-page":"112156","DOI":"10.1016\/j.mce.2024.112156","volume":"584","author":"D Wang","year":"2024","unstructured":"Wang D, Zhang Q, Dong W, Ren S, Wang X, Su C, et al. SGLT2 knockdown restores the Th17\/Treg balance and suppresses diabetic nephropathy in db\/db mice by regulating SGK1 via Na+. Mol Cell Endocrinol. 2024;584:112156. https:\/\/doi.org\/10.1016\/j.mce.2024.112156.","journal-title":"Mol Cell Endocrinol"},{"key":"3323_CR44","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.2337\/db11-0358","volume":"60","author":"K Eller","year":"2011","unstructured":"Eller K, Kirsch A, Wolf AM, Sopper S, Tagwerker A, Stanzl U, et al. Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy. Diabetes. 2011;60:2954\u201362. https:\/\/doi.org\/10.2337\/db11-0358.","journal-title":"Diabetes"},{"key":"3323_CR45","doi-asserted-by":"publisher","unstructured":"Piancone F, La Rosa F, Marventano I, Saresella M, Clerici M. The role of the inflammasome in neurodegenerative diseases. Molecules 2021;26. https:\/\/doi.org\/10.3390\/molecules26040953","DOI":"10.3390\/molecules26040953"},{"key":"3323_CR46","doi-asserted-by":"publisher","unstructured":"Chaurasia SS, Lim RR, Parikh BH, Wey YS, Tun BB, Wong TY, et al. The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy. Sci Rep. 2018;8. https:\/\/doi.org\/10.1038\/s41598-018-21198-z.","DOI":"10.1038\/s41598-018-21198-z"},{"key":"3323_CR47","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/aos.13427","volume":"95","author":"S Loukovaara","year":"2017","unstructured":"Loukovaara S, Piippo N, Kinnunen K, Hytti M, Kaarniranta K, Kauppinen A. NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy. Acta Ophthalmol. 2017;95:803\u20138. https:\/\/doi.org\/10.1111\/aos.13427.","journal-title":"Acta Ophthalmol"},{"key":"3323_CR48","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.4049\/jimmunol.2000574","volume":"205","author":"Z Lu\u017enik","year":"2020","unstructured":"Lu\u017enik Z, Anchouche S, Dana R, Yin J. Regulatory T Cells in Angiogenesis. J Immunol. 2020;205:2557\u201365. https:\/\/doi.org\/10.4049\/jimmunol.2000574.","journal-title":"J Immunol"},{"key":"3323_CR49","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2337\/dc13-2002","volume":"37","author":"R Sim\u00f3","year":"2014","unstructured":"Sim\u00f3 R, Sundstrom JM, Antonetti DA. Ocular anti-VEGF therapy for diabetic retinopathy: The role of VEGF in the pathogenesis of diabetic retinopathy. Diabetes Care. 2014;37:893\u20139. https:\/\/doi.org\/10.2337\/dc13-2002.","journal-title":"Diabetes Care"},{"key":"3323_CR50","doi-asserted-by":"publisher","unstructured":"Sim\u00f3 R, Hern\u00e1ndez C. New Insights into Treating Early and Advanced Stage Diabetic Retinopathy. Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/ijms23158513.","DOI":"10.3390\/ijms23158513"},{"key":"3323_CR51","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1007\/s00125-023-05940-5","volume":"66","author":"R Sim\u00f3","year":"2023","unstructured":"Sim\u00f3 R, Hern\u00e1ndez C. What else can we do to prevent diabetic retinopathy? Diabetologia. 2023;66:1614\u201321. https:\/\/doi.org\/10.1007\/s00125-023-05940-5.","journal-title":"Diabetologia"},{"key":"3323_CR52","doi-asserted-by":"publisher","unstructured":"Sim\u00f3 R, Sim\u00f3-Servat O, Bogdanov P, Hern\u00e1ndez C. Neurovascular unit: A new target for treating early stages of diabetic retinopathy. Pharmaceutics. 2021;13. https:\/\/doi.org\/10.3390\/pharmaceutics13081320.","DOI":"10.3390\/pharmaceutics13081320"},{"key":"3323_CR53","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/aos.14912","volume":"100","author":"MS Thagaard","year":"2022","unstructured":"Thagaard MS, Vergmann AS, Grauslund J. Topical treatment of diabetic retinopathy: a systematic review. Acta Ophthalmol. 2022;100:136\u201347. https:\/\/doi.org\/10.1111\/aos.14912.","journal-title":"Acta Ophthalmol"},{"key":"3323_CR54","doi-asserted-by":"publisher","unstructured":"de la Fuente AG, Dittmer M, Heesbeen EJ, de la Vega Gallardo N, White JA, Young A, et al. Ageing impairs the regenerative capacity of regulatory T cells in mouse central nervous system remyelination. Nat Commun. 2024;15. https:\/\/doi.org\/10.1038\/s41467-024-45742-w.","DOI":"10.1038\/s41467-024-45742-w"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-024-03323-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-024-03323-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-024-03323-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T16:04:42Z","timestamp":1734969882000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-024-03323-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3323"],"URL":"https:\/\/doi.org\/10.1186\/s12974-024-03323-0","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"assertion":[{"value":"31 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were directed in agreement with the European Community (86\/609\/CEE) and the guidelines of the Association for Research in Vision and Ophthalmology (ARVO) for the utilization of laboratory animals. The Animal Care and Use Committee of VHIR (CEEA 14\/21) authorized the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"328"}}